Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check30 days agoChange DetectedRemoved related topics in the page's sidebar: 'Rheumatoid arthritis' and 'MedlinePlus Genetics'. This is a metadata/navigation change that does not modify the study details or results.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics. Updated the site revision from v3.4.2 to v3.4.3; core study content remains unchanged.SummaryDifference0.1%

- Check53 days agoChange DetectedRemoved the 'Rheumatoid arthritis' condition label and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.